腹主动脉瘤腔内修复术后移植物分支闭塞的临床模式、预测因素与结果
该回顾性研究分析了2002至2017年两家郊区教学医院接受EVAR的319例患者,22例出现23条移植物分支闭塞。小直径髂外动脉(≤6 mm)、移植物延伸至髂外动脉及既往髂总动脉支架置入是GLO的显著预测因素;GLO导致显著并发症和死亡。
要点
- 小直径髂外动脉(≤6 mm)、移植物延伸至髂外动脉及既往髂总动脉支架置入是EVAR术后移植物分支闭塞的显著预测因素。
- 23条闭塞分支中,6条未接受任何干预,其余接受了开放取栓、股-股交叉旁路等不同方式处理。
- GLO可导致严重并发症,包括膝上截肢和动脉瘤破裂死亡。
核心结论
- EVAR术后移植物分支闭塞导致显著并发症和死亡。
- EVAR术后GLO的预测因素包括小直径髂外动脉、既往髂总动脉支架置入及移植物分支延伸至髂外动脉。
研究设计与样本
- 回顾性研究,纳入2002至2017年两家中型郊区教学医院接受EVAR的患者,373例中319例纳入分析。
主要发现
- 22例患者出现23条移植物分支闭塞(21例单侧,1例双侧),平均随访9.1±2.1年。
- 有GLO与无GLO患者在平均年龄、性别、腹主动脉瘤大小及高血压、冠心病、糖尿病、慢性阻塞性肺疾病等危险因素方面无统计学显著差异。
- 主动脉-髂总动脉角及髂总动脉-髂外动脉角在两组间无统计学显著差异。
- 髂外动脉直径较小(6 mm或以下)、移植物延伸至髂外动脉及既往髂总动脉支架置入是GLO的显著预测因素。
- 4条分支在EVAR术后1个月内发生GLO,其中2条仅行开放取栓,1条行开放取栓联合腋-股动脉旁路,1条行开放取栓联合自膨式支架置入。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the incidence, clinical patterns, and outcomes of graft limb occlusion (GLO) following endovascular aneurysm repair (EVAR). METHODS: A retrospective study of patients undergoing EVAR from 2002 to 2017 at 2 mid-sized suburban teaching hospitals. The ipsilateral and contralateral aorto-common iliac artery (A-CIA) angle and common iliac artery-external iliac artery (CIA-EIA) angle were determined. The diameter of the EIA, graft extension to the EIA, and prior CIA stenting was recorded. RESULTS: Of the 373 patients who underwent EVAR, 319 were analyzed. 22 patients had 23 limbs with GLO (21 unilateral and 1 bilateral) with a mean follow-up of 9.1 ± 2.1 years. There were no statistically significant differences in mean age, gender, size of the abdominal aortic aneurysm, and risk factors of hypertension, coronary artery disease, diabetes mellitus, and chronic obstructive pulmonary disease in patients with and without GLO. There was no statistically significant difference in A-CIA and CIA-EIA angles. A smaller diameter EIA (6 mm or less), graft extension to EIA, and prior CIA stenting were significant predictors of GLO. Four limbs had GLO within 1 month of EVAR, only open thrombectomy was performed in 2 limbs, open thrombectomy with simultaneous axillo-femoral graft in 1 limb, and open thrombectomy with self-expandable stent placement in 1 limb. 12 limbs had GLO within 1-12 months treated with only open thrombectomy in 3 limbs, open thrombectomy with fasciotomy in 1 limb, open thrombectomy with graft extension to EIA in 1 limb, and crossover femoral-femoral graft performed in 3 limbs. Seven limbs had GLO within 1-5 years with a crossover femoral-femoral graft performed in 4 limbs and open thrombectomy with graft extension to EIA was performed in 1 limb. Six limbs with GLO following EVAR did not undergo any intervention. One patient had an above the knee amputation 3 years following occlusion of the axillo-femoral graft and 1 patient returned in 4 years with an increase in size of the excluded aneurysm leading to acute rupture and death. CONCLUSIONS: GLO leads to significant morbidity and mortality following EVAR. Predictors of GLO following EVAR include a small diameter EIA, prior CIA stenting and graft limb extension to the EIA.
引用
- Chacko P, Hans SS, Nahirniak P, et al. Clinical Patterns, Predictors, and Results of Graft Limb Occlusion following Endovascular Aneurysm Repair. Ann Vasc Surg. 2023. PMID: 36918093. doi:10.1016/j.avsg.2023.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。